Cisplatin is widely used for chemotherapy, but the effectiveness of resistance in tumors may decrease. The new drug created by Urfu scientists moves more effectively even on such tumors, which allows us to rely on success in the fight against stable malignant cells.
The main difference between these complexes is that they prevent the growth and division of tumor cells and violate the work of mitochondria for cells. In experiments on brain cancer, lungs and liver cells, it has been shown that new compounds are effective even in low concentrations, and significantly more substances are required for the effect of cisplatin.
At the current stage of the study, the work has already been completed with the molecular structure of the new complexes, and the following steps include pre -clinical tests.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
